Frontiers | The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease | Pharmacology
ROCK inhibition in models of neurodegeneration and its potential for clinical translation - ScienceDirect
Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis
ROCK Inhibitor Y-27632 | STEMCELL Technologies
ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway | Nature Communications
Retinal Physician - Rho Kinase Inhibitors for Diabetic Macular Edema
ROCK inhibition in models of neurodegeneration and its potential for clinical translation - ScienceDirect
Schematic illustration of rock inhibitor effect for inducing apoptosis... | Download Scientific Diagram
Rho kinase inhibitor - Wikipedia
ROCK Inhibitor Y-27632 | STEMCELL Technologies
ROCK Inhibitor (Y-27632) The ROCK Inhibitor (Y-27632) is available in a 5 mg format & has been optimized & validated for cell culture & Neuroscience applications. | Sigma-Aldrich
Observations from the Field: Efficient hiPS cell culturing without ROCK inhibitors - Biological Industries
Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis
ROCK Inhibitor for Stem Cell Cryopreservation | Tocris Bioscience
Y-27632 2HCl | ≥99%(HPLC) | Selleck | ROCK inhibitor
A Rho-associated coiled-coil containing kinases (ROCK) inhibitor, Y-27632, enhances adhesion, viability and differentiation of human term placenta-derived trophoblasts in vitro
ROCK inhibitor combined with Ca2+ controls the myosin II activation and optimizes human nasal epithelial cell sheets | Scientific Reports
Highly Potent, Cell-Permeable And Selective Inhibitor
ROCK inhibitor combined with Ca2+ controls the myosin II activation and optimizes human nasal epithelial cell sheets | Scientific Reports
GSK269962A is an Orally Active ROCK Inhibitor with Anti-Inflammatory and Vasodilatory Activities - Immune System Research
N-Boc-Y-27632, Rho kinase (ROCK) inhibitor (CAS 671816-04-9) (ab143784) | Abcam
Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy | NEJM
